US Broker Ratings

Alphatec Holdings, Inc. (ATEC): Investor Outlook Highlights Nearly 93% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC) is emerging as an intriguing player in the healthcare sector, specifically within the medical devices industry. With its focus on cutting-edge technologies for the surgical..

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook and Growth Potential with 12% Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is an intriguing player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $865.54 million, this..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 14.84% Upside Potential with Strong Buy Ratings

Surgery Partners, Inc. (SGRY), a prominent player in the U.S. healthcare sector, stands at an intriguing crossroads for investors. With a market capitalization of $2.1 billion, this Brentwood, Tennessee-based company..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Exploring Growth Potential with 4 Buy Ratings and a 4.29% Upside

Amneal Pharmaceuticals, Inc. (AMRX) is capturing the attention of investors with its promising growth potential and strong market position within the healthcare sector. Known for its diversified portfolio of generics,..

MiMedx Group, Inc (MDXG) Investor Outlook: Exploring a 52.42% Potential Upside Amidst Biotech Innovations

For investors eyeing the biotechnology sector, MiMedx Group, Inc. (NASDAQ: MDXG) presents an intriguing opportunity, especially given its reported potential upside of 52.42%. This healthcare-focused company, based in Marietta, Georgia,..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 264% Upside

Opko Health, Inc. (NASDAQ: OPK), a healthcare company specializing in diagnostics and research, is drawing investor attention with its substantial upside potential. Despite current challenges, the company’s future prospects, driven..

NeoGenomics, Inc. (NEO) Stock Analysis: Unveiling a 13.92% Upside Potential in Cancer Diagnostics

NeoGenomics, Inc. (NASDAQ: NEO), a leader in cancer diagnostics, is capturing investor attention with a potential 13.92% upside based on the current average target price. As a company operating in..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Potential Upside of Over 31% Amid Healthcare Sector Dynamics

Brookdale Senior Living Inc. (NYSE: BKD) stands as a significant player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $3.57 billion, Brookdale..

Omnicell, Inc. (OMCL) Stock Analysis: Exploring a 35% Potential Upside Amidst Strong Buy Ratings

Omnicell, Inc. (NASDAQ: OMCL), a leading player in the healthcare technology sector, is making waves with its innovative solutions for medication management and adherence systems. Headquartered in Fort Worth, Texas,..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Biotech Powerhouse with 131.70% Potential Upside

Janux Therapeutics, Inc. (NASDAQ: JANX), a rising star in the biotechnology sector, has captured the attention of investors with its innovative approach to cancer treatment. The company’s clinical stage biopharmaceutical..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Strong Revenue Growth and Impressive ROI Capture Investor Attention

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is carving out a niche in the biotechnology sector with its focus on therapies for autoimmune diseases. Based in Edmonton, Canada, this biopharmaceutical company is..

Evolent Health, Inc. (EVH) Investor Outlook: Navigating Growth with a Strong Buy Consensus

Evolent Health, Inc. (NYSE: EVH), a key player in the healthcare sector specializing in health information services, presents an intriguing prospect for investors, particularly with its current consensus rating of..

Immunocore Holdings plc (IMCR): Investor Outlook and 86% Potential Upside

Immunocore Holdings plc (NASDAQ: IMCR), a key player in the biotech sector, is capturing investor attention with its impressive potential upside of 86.10%. Specializing in immunomodulating medicines, the UK-based firm..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Volatility in the Chinese Pharmaceutical Sector

As individual investors scour the globe for opportunities, BGM Group Ltd. (BGM), a China-based pharmaceutical and chemical company, presents an intriguing case study within the healthcare sector. Despite its modest..

Envista Holdings Corporation (NVST) Stock Analysis: 10.72% Upside Potential in the Healthcare Sector

Envista Holdings Corporation (NYSE: NVST) stands as a noteworthy contender in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $4.33 billion, Envista..

Integra LifeSciences Holdings (IART) Stock Analysis: Navigating Opportunities in the Medical Device Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, specifically within the medical devices industry, stands at a pivotal juncture for investors. Headquartered in Princeton, New..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Striking Potential with a 29.94% Upside

Investors eyeing the healthcare sector might want to focus on Indivior Pharmaceuticals, Inc. (NASDAQ: INDV), a prominent player in the specialty and generic drug manufacturing industry. Known for its innovative..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Revenue Growth Amidst Valuation Challenges

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) has garnered significant attention in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Seattle, Washington, this commercial-stage company is renowned for..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 24% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (AHCO) is making strides in the healthcare sector, specifically in the medical devices industry. With a market capitalization of $1.49 billion, this U.S.-based company is a key player..

Enovis Corporation (ENOV) Stock Analysis: A 51.74% Upside Potential with Strong Buy Ratings

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its impressive potential upside of 51.74% and a slew of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds